Company intelligence / Profile preview

TingSN

Nanjing, Jiangsu, Chinatingsn.com ↗

Ownership: Private
Development stage: Commercial

Overview

TingSN specializes in developing advanced ultrasound-based medical devices for cardiac electrophysiology procedures and structural heart disease interventions. Its flagship offerings include a 3D echocardiographic mapping system and single-use intracardiac echocardiography catheters. The company has raised over $30 million in funding through Series B rounds with backing from major healthcare investors. Clinical adoption is ongoing with successful product launches reported.

Therapeutic areas: Cardiovascular
Modalities: DeviceUltrasound-based diagnostic and interventional devices
Industry: Medical Imaging

Beyond the preview

Go deeper on TingSN.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TingSN.

Explore the full profile